Loading...

Pan Kathy

Title(s)Member, CTSI
SchoolCTSI
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. BrintzenhofeSzoc K, Krok-Schoen JL, Canin B, Parker I, MacKenzie AR, Koll T, Vankina R, Hsu CD, Jang B, Pan K, Lund JL, Starbuck E, Shahrokni A. The underreporting of phase III chemo-therapeutic clinical trial data of older patients with cancer: A systematic review. J Geriatr Oncol. 2020 Jan 10. PMID: 31932259.
      View in: PubMed
    2. Chebet JJ, Thomson CA, Kohler LN, Ehiri JE, Luo J, Cheng TD, Pan K, Chlebowski RT, Nassir R, Sealy-Jefferson S, Manson JE, Saquib N, Bell ML. Association of Diet Quality and Physical Activity on Obesity-Related Cancer Risk and Mortality in Black Women: Results from the Women's Health Initiative. Cancer Epidemiol Biomarkers Prev. 2020 Jan 08. PMID: 31915146.
      View in: PubMed
    3. Chlebowski RT, Rapp S, Aragaki AK, Pan K, Neuhouser ML, Snetselaar LG, Manson JE, Wactawski-Wende J, Johnson KC, Hayden K, Baker LD, Henderson VW, Garcia L, Qi L, Prentice RL. Low-fat dietary pattern and global cognitive function: Exploratory analyses of the Women's Health Initiative (WHI) randomized Dietary Modification trial. EClinicalMedicine. 2020 Jan; 18:100240. PMID: 31938786.
      View in: PubMed
    4. Arthur RS, Xue X, Kamensky V, Chlebowski RT, Simon M, Luo J, Shadyab AH, Neuhouser ML, Banack H, Ho GYF, Lane DS, Pan K, Reding KW, Wassertheil-Smoller S, Dannenberg AJ, Rohan TE. The association between DXA-derived body fat measures and breast cancer risk among postmenopausal women in the Women's Health Initiative. Cancer Med. 2019 Dec 25. PMID: 31875358.
      View in: PubMed
    5. Pan K, Bosserman L, Chlebowski RT. Reply to F. Conforti et al. J Clin Oncol. 2019 Jul 20; 37(21):1840-1841. PMID: 31173556.
      View in: PubMed
    6. Pan K, Gong J, Huynh K, Cristea M. Current Systemic Treatment Landscape of Advanced Gynecologic Malignancies. Target Oncol. 2019 06; 14(3):269-283. PMID: 31069647.
      View in: PubMed
    7. Pan K, Luo J, Aragaki AK, Chlebowski RT. Weight loss, diet composition and breast cancer incidence and outcome in postmenopausal women. Oncotarget. 2019 May 03; 10(33):3088-3092. PMID: 31139321.
      View in: PubMed
    8. Pan K, Nelson RA, Wactawski-Wende J, Lee DJ, Manson JE, Aragaki AK, Mortimer JE, Phillips LS, Rohan T, Ho GYF, Saquib N, Shadyab AH, Nassir R, Rhee JJ, Hurria A, Chlebowski RT. Insulin Resistance and Cancer-Specific and All-Cause Mortality in Postmenopausal Women: The Women's Health Initiative. J Natl Cancer Inst. 2019 Apr 26. PMID: 31184362.
      View in: PubMed
    9. Michels KA, Brinton LA, Wentzensen N, Pan K, Chen C, Anderson GL, Pfeiffer RM, Xu X, Rohan TE, Trabert B. Postmenopausal Androgen Metabolism and Endometrial Cancer Risk in the Women's Health Initiative Observational Study. JNCI Cancer Spectr. 2019 Sep; 3(3):pkz029. PMID: 31321379.
      View in: PubMed
    10. Trabert B, Michels KA, Anderson GL, Brinton LA, Falk RT, Geczik AM, Harris HR, Pan K, Pfeiffer RM, Qi L, Rohan T, Wentzensen N, Xu X. Circulating androgens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study. Int J Cancer. 2019 Oct 15; 145(8):2051-2060. PMID: 30684389.
      View in: PubMed
    11. Pan K, Bosserman LD, Chlebowski RT. Ovarian Suppression in Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. J Clin Oncol. 2019 Apr 10; 37(11):858-861. PMID: 30742565.
      View in: PubMed
    12. Iyengar NM, Arthur R, Manson JE, Chlebowski RT, Kroenke CH, Peterson L, Cheng TD, Feliciano EC, Lane D, Luo J, Nassir R, Pan K, Wassertheil-Smoller S, Kamensky V, Rohan TE, Dannenberg AJ. Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index: A Secondary Analysis of a Randomized Clinical Trial and Observational Study. JAMA Oncol. 2019 02 01; 5(2):155-163. PMID: 30520976.
      View in: PubMed
    13. Chlebowski RT, Mortimer JE, Crandall CJ, Pan K, Manson JE, Nelson R, Johnson KC, Vitolin MZ, Lane D, Wactawski-Wende J, Kwan K, Stefanick ML. Persistent vasomotor symptoms and breast cancer in the Women's Health Initiative. Menopause. 2018 12 28; 26(6):578-587. PMID: 30601454.
      View in: PubMed
    14. Uche A, Vankina R, Gong J, Cho M, Yeh JJ, Kim P, Pan K. Capecitabine-induced hypertriglyceridemia: a rare but clinically relevant treatment-related adverse event. J Gastrointest Oncol. 2018 Dec; 9(6):1213-1219. PMID: 30603144.
      View in: PubMed
    15. Chlebowski RT, Pan K. Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. N Engl J Med. 2018 Oct 25; 379(17):1684. PMID: 30358972.
      View in: PubMed
    16. Chlebowski RT, Aragaki AK, Anderson GL, Simon MS, Manson JE, Neuhouser ML, Pan K, Stefanic ML, Rohan TE, Lane D, Qi L, Snetselaar L, Prentice RL. Association of Low-Fat Dietary Pattern With Breast Cancer Overall Survival: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trial. JAMA Oncol. 2018 10 01; 4(10):e181212. PMID: 29800122.
      View in: PubMed
    17. Arthur R, Kabat GC, Kim MY, Ho GYF, Chlebowski RT, Pan K, Rohan TE. Adiposity, history of diabetes, and risk of pancreatic cancer in postmenopausal women. Ann Epidemiol. 2019 01; 29:23-29.e1. PMID: 30449532.
      View in: PubMed
    18. Beverly CM, Naughton MJ, Pennell ML, Foraker RE, Young G, Hale L, Feliciano EMC, Pan K, Crane TE, Danhauer SC, Paskett ED. Change in longitudinal trends in sleep quality and duration following breast cancer diagnosis: results from the Women's Health Initiative. NPJ Breast Cancer. 2018; 4:15. PMID: 29978034.
      View in: PubMed
    19. Gong J, Pan K, Fakih M, Pal S, Salgia R. Value-based genomics. Oncotarget. 2018 Mar 20; 9(21):15792-15815. PMID: 29644010.
      View in: PubMed
    20. Pan K, Hurria A, Chlebowski RT. Breast cancer survivorship: state of the science. Breast Cancer Res Treat. 2018 Apr; 168(3):593-600. PMID: 29332134.
      View in: PubMed
    21. Chlebowski RT, Pan K. Complexity of intermittent letrozole adjuvant therapy. Lancet Oncol. 2018 01; 19(1):13-15. PMID: 29158010.
      View in: PubMed
    22. Pan K, Lin EM, Chlebowski RT. Emerging combination endocrine therapies for advanced breast cancer. Breast J. 2018 03; 24(2):214-215. PMID: 28744960.
      View in: PubMed
    23. Chlebowski RT, Pan K, Nananda F. Response. Breast Cancer Res Treat. 2017 06; 163(3):633-634. PMID: 28353060.
      View in: PubMed
    24. Lohmann AE, Goodwin PJ, Chlebowski RT, Pan K, Stambolic V, Dowling RJ. Association of Obesity-Related Metabolic Disruptions With Cancer Risk and Outcome. J Clin Oncol. 2016 12 10; 34(35):4249-4255. PMID: 27903146.
      View in: PubMed
    25. Chlebowski RT, Pan K, Col NF. Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer. Breast Cancer Res Treat. 2017 01; 161(2):185-190. PMID: 27785653.
      View in: PubMed
    26. Pan K, Chlebowski RT, Simon MS, Ray RM, Livaudais-Toman J, Sullivan SD, Stefanick ML, Wallace RB, LeBoff M, Bluhm EC, Paskett ED. Medication use trajectories of postmenopausal breast cancer survivors and matched cancer-free controls. Breast Cancer Res Treat. 2016 Apr; 156(3):567-576. PMID: 27075917.
      View in: PubMed
    27. Chlebowski RT, Pan K. Exemestane with ovarian suppression in premenopausal breast cancer. N Engl J Med. 2014 10 02; 371(14):1358. PMID: 25271612.
      View in: PubMed
    28. Pan K, Chlebowski RT. Adjuvant endocrine therapy of perimenopausal and recently postmenopausal women with hormone receptor-positive breast cancer. Clin Breast Cancer. 2014 Jun; 14(3):147-53. PMID: 24503025.
      View in: PubMed